Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway

Mariateresa Fulciniti, PhD, Rajya Bandi, Nicola Amodio, PhD, Rao H. Prabhala, Ph.D., Mansa Munshi, PhD, Lian Xu, Guang Yang, PhD, Zachary Hunter, Kenneth C. Anderson, MD, Steven Peter Treon, MD, MA, PhD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3065.

https://doi.org/10.1182/blood.V122.21.3065.3065

Published: 2013

Journal Articles

Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma

Mariateresa Fulciniti, PhD, Nicola Amodio, PhD, Rajya Bandi, Rao H. Prabhala, Ph.D., Sophia Adamia, PhD, Teresa Calimeri, MD, Lavinia Biamonte, PhD, Marzia Leotta, MD, Kenneth C. Anderson, MD, Pierfrancesco Tassone, MD, Munshi C Nikhil, MD

Blood (2013) 122 (21): 122.

https://doi.org/10.1182/blood.V122.21.122.122

Published: 2013

Journal Articles

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Rao H. Prabhala, Ph.D., Mariateresa Fulcinitti, PhD, Dheeraj Pelluru, PhD, Harsha K. Prabhala, MS, Naim Rashid, PhD, Adam Sperling, MD, PhD, Puru Nanjappa, MS, Saem Lee, B.A., Andreea Negroiu, MD, Suzan Lazo-Kallanian, BS, Aditya Munshi, MD, Paul G. Richardson, MD, John Daley, PhD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2013) 122 (21): 3113.

https://doi.org/10.1182/blood.V122.21.3113.3113

Published: 2013

Journal Articles

Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma

Rao H. Prabhala, Ph.D., Andreea Negroiu, MD, Saem Lee, B.A., Mariateresa Fulciniti, PhD, Puru Nanjappa, Ms, Harsha K. Prabhala, Adithya Munshi, MD, Irene M. Ghobrial, MD, Paul G. Richardson, MD, Jacob Laubach, MD, John Daley, PhD, Steven P. Treon, M.D., Ph.D., Charles Allam, MD, Kenneth C. Anderson, MD, Nikhil C Munshi, MD

Blood (2012) 120 (21): 3986.

https://doi.org/10.1182/blood.V120.21.3986.3986

Published: 2012

Journal Articles

Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma

Jooeun Bae, PhD, Rao H. Prabhala, Ph.D., Weihua Song, MD, Yu-Tzu Tai, PhD, Kenneth C. Anderson, Nikhil C Munshi, MD

Blood (2012) 120 (21): 5039.

https://doi.org/10.1182/blood.V120.21.5039.5039

Published: 2012

Journal Articles

Targeting Sp1 Transactivation In Waldenstrom's Macroglobulinemia: a Novel Therapeutic Option

Mariateresa Fulciniti, Samir B. Amin, MBBS, Varuna Mohan, Guang Yang, MD, Puru Nanjappa, Pierfrancesco Tassone, Rao H Prabhala, Ph.D., Li Cheng, Kenneth C. Anderson, Steven P. Treon, MD, PhD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 120.

https://doi.org/10.1182/blood.V116.21.120.120

Published: 2010

Journal Articles

Interleukin-17 and T H 17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications

Rao H Prabhala, Ph.D., Dheeraj Pelluru, PhD, Mariateresa Fulciniti, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, John Daley, PhD, Steven P. Treon, MD, PhD, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 446.

https://doi.org/10.1182/blood.V116.21.446.446

Published: 2010

Journal Articles

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Rao H Prabhala, PH.D., Mariateresa Fulciniti, PhD, Dheeraj Pelluru, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, Weihua Song, MD, Constantine S. Mitsiades, MD, PhD, Konstantinos Lefkimmiatis, PhD, Yu-Tzu Tai, PhD, Irene Ghobrial, MD, Paul Richardson, MD, John Daley, Kenneth C. Anderson, MD, Seth Ettenberg, Franco Di Padova, Nikhil C. Munshi, MD

Blood (2010) 116 (21): 456.

https://doi.org/10.1182/blood.V116.21.456.456

Published: 2010

Journal Articles

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Nikhil C. Munshi, M.D., Saem Lee, B.A., Suman Kambhampati, M.D., Abid Mohiuddin, M.D., Michal Rose, M.D., Caroline Behler, M.D., Andrew Han, B.A., Yvonne Efebera, M.D., Antoun Houranieh, RPh., M.S., Ph.D., Mary T. Brophy, M.D., Abraham Zimelman, M.D., Rao H Prabhala, Ph.D., Hussain I. Saba, M.D, Ph.D, Catherine Klein, M.D., Paulette Mehta, M.D, MPH, Teresa Hayes, M.D., David Roodman, M.D, Ph.D, Alan K. Lichtenstein, M.D.

Blood (2010) 116 (21): 3061.

https://doi.org/10.1182/blood.V116.21.3061.3061

Published: 2010

NARROW

Sp1 Inhibition Affects Cell Growth and Survival In Waldenstrom’s Macroglobulinemia Through a MYD88-Independent Pathway

Mir-23b Plays a Critical Role As a Tumor Suppressor miRNA In Multiple Myeloma

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma

Induction of T Cell Immunity Using a Multipeptide Cocktail Containing XBP1, CD138 and CS1 Peptides in Smoldering Multiple Myeloma

Targeting Sp1 Transactivation In Waldenstrom's Macroglobulinemia: a Novel Therapeutic Option

Interleukin-17 and T H 17 Pathway Supports Waldenstrom's Macroglobulinemia Cell-Growth: Potential Therapeutic Implications

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Interim Results of An Ongoing Clinical Study Suggests Efficacy and Improved Toxicity Profile with Once a Week Bortezomib with Dexamethasone In Newly Diagnosed Multiple Myeloma Patients with Older Age and Co-Morbidities

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only